White label ELPA - ClinicalTrials.eu

Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

Recruiting

2 1 1
Investigated diseases:
- Dyslipidaemia
Investigated drugs:
- Rbd5044 Sodium
Study on Rectal Cancer Treatment with Radiotherapy, Atezolizumab, and Bevacizumab for Patients with Low- to Intermediate-Risk

Recruiting

2 1 1 1
Investigated diseases:
- Colorectal cancer
Investigated drugs:
- Atezolizumab
- Bevacizumab
Study on Preventing Opioid-Induced Constipation in Advanced Cancer Patients Using Magnesium Hydroxide and Macrogol 3350 Combination

Recruiting

3 1 1 1
Investigated diseases:
- Neoplasm malignant
Investigated drugs:
Evaluation of Two Prednisolone Treatment Strategies for Newly Diagnosed, Untreated Rheumatoid Arthritis Patients

Recruiting

3 1 1 1
Investigated diseases:
- Rheumatoid arthritis
Investigated drugs:
- Prednisolone
Study on Anakinra for Patients with Intracerebral Hemorrhage to Reduce Brain Swelling After Stroke

Recruiting

2 1 1 1
Investigated diseases:
- Cerebral haemorrhage
Investigated drugs:
- Anakinra
Study of MEN1703 and Glofitamab for Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Recruiting

2 1 1 1 1
Investigated diseases:
- B-cell lymphoma recurrent
- B-cell lymphoma refractory
Investigated drugs:
Study of hydroxychloroquine with low-dose corticosteroids compared to medium-dose corticosteroids in patients with pulmonary sarcoidosis

Recruiting

3 1 1 1
Investigated diseases:
- Pulmonary sarcoidosis
Investigated drugs:
Study on Timing of Chemotherapy with Paclitaxel Albumin-Bound and Drug Combination for Patients with Metastatic Pancreatic Cancer

Recruiting

3 1 1 1
Investigated diseases:
- Pancreatic carcinoma
- Pancreatic carcinoma metastatic
Investigated drugs:
Study on the Safety and Effectiveness of ART0380 Alone or with Gemcitabine or Irinotecan for Patients with Advanced or Metastatic Solid Tumors

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

Recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
- Dasatinib
- Venetoclax
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies